Dr. Marcia Cruz-Correa join Dr. John Marshall at the 2016 Ruesch Annual Symposium to discuss some of the key issues that Latino populations face in regard to colorectal cancer that may distinguish them from other populations.
Panelists John Marshall, MD; Tanios Bekaii-Saab, MD; Johanna Bendell, MD; and Alan P. Venook, MD, provide insight on the use of regorafenib and TAS-102 in third-line colorectal cancer and how to set expectations with regard to treatment response.
Panelists John Marshall, MD; Johanna Bendell, MD; Tanios Bekaii-Saab, MD; and Alan P. Venook, MD, discuss the need for longer-term strategies in metastatic colorectal cancer because of an increased likelihood that a patient will need a third line of therapy.
CURE Media Group partners with the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center and the Colon Cancer Alliance in preparation for the 12th Annual Scope It Out Run/Walk.
Dr. John Marshall, the director of the Ruesch Center for the Cure of Gastrointestinal Cancer at Georgetown University, joined Tom Ashbrook for On Point on NPR on March 1st to discuss young adult colorectal cancer.
Cancers of the colon and rectum have been declining in older adults in recent decades and have always been considered rare in young people. But scientists are reporting a sharp rise in colorectal cancers in adults as young as their 20s and 30s, an ominous trend.